Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00249730|
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : December 19, 2006
|Condition or disease||Intervention/treatment||Phase|
|Impotence||Drug: Sildenafil||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||510 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction|
|Study Start Date :||October 2005|
- Change in IIEF erectile function domain score at the end of double blind treatment.
- Change in other IIEF domain scores; Response to other questionnaires regarding treatment satisfaction, safety and tolerability.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249730
Show 39 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|